GIT Cancer NM Flashcards
Esophageal cancer stage II
IIA - lower 1/3 T3
IIB - upper 2/3 T3
Esophageal cancer unresectable
Aorta, vertebral body, trachea, bronchi, lung
Esophageal cancer stage III
N1
Esophageal cancer M
Liver
Lung
Bone
Smoking + alco
Esophagus
SCC, middle 1/3
Obesity, reflux
Adenocarcinoma, distal, GEJ within proximal 5 cm
Esophageal cancer diagnosis
EUS - most sensitive for tumor depth
FDG - more sensitive than CT in LN
Esophageal cancer FDG indication
Distant MTS
LN involvement
Response to neoadj treatment
Local recurrence - - dd fibrosis vs edema
False negative - - small T1-2, necrotic, mucinous
3-4 weeks after chemoradio
6 weeks after surgery
FDG T staging esophageal cancer
T1-2 - asymmetric thickening
T3 - wall thickening >5 mm or mass causing luminal obstruction
Esophageal cancer LN
> 1 cm in short axis or >5 mm supraclavicular
Upper esophagus - cervical and mediastinal
Lower esophagus - abdominal
Esophageal cancer treatment
Chemo radio + surgery
T3 dd esophageal vs gastric
Esophageal - no serosa - - adventitia - - easy to spread
Gastric - subserosa - serosa
Gastric T4
Not duodenum or esophagus
Gastric cancer LN
Sister Mary Joseph’s LN - Periumbilical
Celiac >6 mm
Perigastric >8 mm
Clustering >3 LN
Risk for LN:
T4, tumor >2 cm, ulcer, mucinous
Gastric cancer M
Liver
Peritoneum - - Krukenberg
Lung
Bone
Gastric cancer type
Adenocarcinoma 90%
Intestinal type - older, distal, pernicious anemia
Diffuse type (signet ring cell) - <50 y, cardia, linitis plastica (diffuse thickening), reflux, obesity, ILC breast ca